These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37530098)

  • 1. Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial.
    van de Bovenkamp AA; Geurkink KTJ; Oosterveer FTP; de Man FS; Kok WEM; Bronzwaer PNA; Allaart CP; Nederveen AJ; van Rossum AC; Bakermans AJ; Handoko ML
    ESC Heart Fail; 2023 Oct; 10(5):2998-3010. PubMed ID: 37530098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study.
    van de Bovenkamp AA; Bakermans AJ; Allaart CP; Nederveen AJ; Kok WEM; van Rossum AC; Handoko ML
    Neth Heart J; 2020 Jun; 28(6):312-319. PubMed ID: 32162204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
    Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
    Hundertmark MJ; Adler A; Antoniades C; Coleman R; Griffin JL; Holman RR; Lamlum H; Lee J; Massey D; Miller JJJJ; Milton JE; Monga S; Mózes FE; Nazeer A; Raman B; Rider O; Rodgers CT; Valkovič L; Wicks E; Mahmod M; Neubauer S
    Circulation; 2023 May; 147(22):1654-1669. PubMed ID: 37070436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
    Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
    JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Berg-Hansen K; Gopalasingam N; Christensen KH; Ladefoged B; Andersen MJ; Poulsen SH; Borlaug BA; Nielsen R; Møller N; Wiggers H
    Circulation; 2024 May; 149(19):1474-1489. PubMed ID: 38533643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress Trial.
    Backhaus SJ; Lange T; George EF; Hellenkamp K; Gertz RJ; Billing M; Wachter R; Steinmetz M; Kutty S; Raaz U; Lotz J; Friede T; Uecker M; Hasenfuß G; Seidler T; Schuster A
    Circulation; 2021 Apr; 143(15):1484-1498. PubMed ID: 33472397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction.
    Burrage MK; Hundertmark M; Valkovič L; Watson WD; Rayner J; Sabharwal N; Ferreira VM; Neubauer S; Miller JJ; Rider OJ; Lewis AJM
    Circulation; 2021 Nov; 144(21):1664-1678. PubMed ID: 34743560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.
    Coats CJ; Pavlou M; Watkinson OT; Protonotarios A; Moss L; Hyland R; Rantell K; Pantazis AA; Tome M; McKenna WJ; Frenneaux MP; Omar R; Elliott PM
    JAMA Cardiol; 2019 Mar; 4(3):230-235. PubMed ID: 30725091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.
    Verbrugge FH; Omote K; Reddy YNV; Sorimachi H; Obokata M; Borlaug BA
    Eur Heart J; 2022 May; 43(20):1941-1951. PubMed ID: 35139159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.
    Armstrong PW; Lam CSP; Anstrom KJ; Ezekowitz J; Hernandez AF; O'Connor CM; Pieske B; Ponikowski P; Shah SJ; Solomon SD; Voors AA; She L; Vlajnic V; Carvalho F; Bamber L; Blaustein RO; Roessig L; Butler J;
    JAMA; 2020 Oct; 324(15):1512-1521. PubMed ID: 33079152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.
    Chieng D; Sugumar H; Segan L; Tan C; Vizi D; Nanayakkara S; Al-Kaisey A; Hawson J; Prabhu S; Voskoboinik A; Finch S; Morton JB; Lee G; Mariani J; La Gerche A; Taylor AJ; Howden E; Kistler PM; Kalman JM; Kaye DM; Ling LH
    JACC Heart Fail; 2023 Jun; 11(6):646-658. PubMed ID: 36868916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.
    Pierce JD; Mahoney DE; Hiebert JB; Thimmesch AR; Diaz FJ; Smith C; Shen Q; Mudaranthakam DP; Clancy RL
    BMC Cardiovasc Disord; 2018 Apr; 18(1):57. PubMed ID: 29606104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction.
    Telles F; Nanayakkara S; Evans S; Patel HC; Mariani JA; Vizi D; William J; Marwick TH; Kaye DM
    Eur J Heart Fail; 2019 Apr; 21(4):495-505. PubMed ID: 30652393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERCA2a Agonist Effects on Cardiac Performance During Exercise in Heart Failure With Preserved Ejection Fraction.
    Sarma S; MacNamara JP; Hieda M; Howden EJ; Lawley JS; Livingston S; Samels M; Levine BD
    JACC Heart Fail; 2023 Jul; 11(7):760-771. PubMed ID: 37086245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
    van Empel VP; Mariani J; Borlaug BA; Kaye DM
    J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; MacNamara JP; Dias KA; Samels M; Palmer D; Livingston S; Morris M; Levine BD
    Circulation; 2021 Sep; 144(12):934-946. PubMed ID: 34543068
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.